Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy.
暂无分享,去创建一个
O. Mir | F. Goldwasser | R. Coriat | S. Ropert | P. Boudou-Rouquette | J. Durand | Romain Coriat | J. Alexandre | Jérôme Alexandre | François Goldwasser | Olivier Mir | Stanislas Ropert | Jean-Philippe Durand | Pascaline Boudou-Rouquette | Priscille Forgeot d'Arc | Idalie Martin | I. Martín | Priscille Forgeot d'Arc
[1] K. Kerr,et al. The impact of follow-up telephone calls to patients after hospitalization. , 2001, Disease-a-month : DM.
[2] J. Hay,et al. Economic Burden of Haematological Adverse Effects in Cancer Patients , 2007, Clinical drug investigation.
[3] J. D'Amore,et al. Does telephone follow-up predict patient satisfaction and readmission? , 2011, Population health management.
[4] A. Jemal,et al. Global Cancer Statistics , 2011 .
[5] C. Peschel,et al. Management of Febrile Neutropenia – a German Prospective Hospital Cost Analysis in Lymphoproliferative Disorders, Non-Small Cell Lung Cancer, and Primary Breast Cancer , 2011, Oncology Research and Treatment.
[6] G. Lyman,et al. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients , 2006, Cancer.
[7] C. Bennett,et al. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. , 2007, The oncologist.
[8] K. Olsen. Patient complexity and GPs' income under mixed remuneration. , 2012, Health economics.
[9] B. Riegel,et al. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. , 2002, Archives of internal medicine.
[10] Quint Studer. How Healthcare Wins with Consumers Who Want More , 2003, Frontiers of Health Services Management.
[11] A. Bottomley,et al. Treatment satisfaction as an outcome measure in cancer clinical treatment trials , 2002, Expert review of pharmacoeconomics & outcomes research.
[12] Bertrand Knebelmann,et al. An observational study of bevacizumab-induced hypertension as a clinical biomarker of antitumor activity. , 2011, The oncologist.
[13] G. Peterson. Practical utility of case-management telephone intervention in heart failure? , 2002, Archives of internal medicine.
[14] J. Bonneterre,et al. Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.